Neuren tops health stocks list with gain of 100+ per cent
MELBOURNE: Neuren’s focus on rare neurological conditions in children instead of targeting higher-profile conditions such
MELBOURNE: Neuren’s focus on rare neurological conditions in children instead of targeting higher-profile conditions such